CSIMarket
 


Zoetis Inc.  (ZTS)
Other Ticker:  
 
 

ZTS's EPS Net Growth by Quarter and Year

Zoetis's EPS Net results by quarter and year




ZTS EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.82 0.16 0.31
III Quarter September - 0.71 0.61 0.48
II Quarter June 0.77 0.79 0.50 0.45
I Quarter March 0.65 0.72 0.48 0.41
FY   1.42 3.04 1.75 1.65



ZTS EPS Net second quarter 2019 Y/Y Growth Comment
Zoetis Inc. reported decrease in EPS Net in the second quarter by -2.53% to $ 0.77 , from the same quarter in 2018.
The decrease in the second quarter Zoetis Inc.'s EPS Net compares unfavorably to the Company's average EPS Net growth of 5.88%.

Looking into second quarter results within Major Pharmaceutical Preparations industry 16 other companies have achieved higher EPS Net growth. While Zoetis Inc.' s EPS Net decline of -2.53% ranks overall at the positon no. 864 in the second quarter.




ZTS EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 412.5 % -48.39 % 675 %
III Quarter September - 16.39 % 27.08 % 26.32 %
II Quarter June -2.53 % 58 % 11.11 % -
I Quarter March -9.72 % 50 % 17.07 % 24.24 %
FY   - 73.71 % 6.06 % -

Financial Statements
Zoetis's second quarter 2019 EPS Net $ 0.77 ZTS's Income Statement
Zoetis's second quarter 2018 EPS Net $ 0.79 Quarterly ZTS's Income Statement
New: More ZTS's historic EPS Net Growth >>


ZTS EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 15.49 % -73.77 % -35.42 %
III Quarter September - -10.13 % 22 % 6.67 %
II Quarter June 18.46 % 9.72 % 4.17 % 9.76 %
I Quarter March -20.73 % 350 % 54.84 % 925 %
FY (Year on Year)   - 73.71 % 6.06 % -




EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #62
Overall #864

EPS Net Y/Y Growth Statistics
High Average Low
68.09 % 5.88 % -28.8 %
(June 30. 2016)   (June 30. 2015)
EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #62
Overall #864
EPS Net Y/Y Growth Statistics
High Average Low
68.09 % 5.88 % -28.8 %
(June 30. 2016)   (June 30. 2015)

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Zoetis's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
837.46 % 49.5 % -88.49 %
(Apr 03 2016)  


ZTS's II. Quarter Q/Q EPS Net Comment
Zoetis Inc. achieved in the II. Quarter 2019 below company average EPS Net jump of 18.46% quarter on quarter, to $ 0.77 .

Albeit the II. Quarter 2019 results were lower than the ordinary of 49.5 %, it was still promising story, as the current improvement, eclipses the 9.72% EPS Net rise in the II. Quarter 2018

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher EPS Net quarter on quarter growth. While Zoetis's EPS Net growth quarter on quarter, overall rank is 443.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #29
Overall #443
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #29
Overall #443
EPS Net Q/Q Growth Statistics
High Average Low
837.46 % 49.5 % -88.49 %
(Apr 03 2016)  


ZTS's II. Quarter Q/Q EPS Net Comment
Zoetis Inc. achieved in the II. Quarter 2019 below company average EPS Net jump of 18.46% quarter on quarter, to $ 0.77 .

Even if the II. Quarter 2019 ZTS's performance was beneath the ordinary of 49.5 %, that has been still promising news, as the current surge, outshines the 9.72% EPS Net growth in the II. Quarter a year ago

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher EPS Net quarter on quarter growth. While Zoetis's EPS Net growth quarter on quarter, overall rank is 443.


Zoetis's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative EPS Net 12 Months Ending $ 2.95 $ 2.97 $ 2.49 $ 2.38 $ 2.28
Y / Y EPS Net Growth (TTM) 29.58 % 49.47 % 31.29 % 25.26 % 28.81 %
Year on Year EPS Net Growth Overall Ranking # 717 # 898 # 224 # 703 # 897
Seqeuential EPS Net Change (TTM) -0.67 % -2.3 % 9.41 % 4.39 % 14.57 %
Seq. EPS Net Growth (TTM) Overall Ranking # 864 # 976 # 243 # 583 # 589




Cumulative EPS Net growth Comment
With the quarterly EPS Net reported in the Jun 30 2019 period, Zoetis's cumulative twelve months EPS Net were $ 3 , company would post below average annual EPS Net growth of 14.57% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Zoetis's EPS Net growth from the 0.65% growth in Mar 31 2019.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 717, from total ranking in previous quarter at 898.

EPS Net TTM Q/Q Growth Statistics
High Average Low
68.09 %
5.88 %
-28.8 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 17
Healthcare Sector # 54
Overall # 717

EPS Net TTM Y/Y Growth Statistics
High Average Low
141.32 %
30.31 %
-41.08 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 62
S&P 500 # 864
Cumulative EPS Net growth Comment
With the quarterly EPS Net reported in the Jun 30 2019 period, Zoetis's cumulative twelve months EPS Net were $ 3 , company would post below average annual EPS Net growth of -41.08% year on year, if the fiscal year would end at Jun 30 2019.
A slow-down in the Zoetis's EPS Net growth from the 0.65% growth in Mar 31 2019.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 717, from total ranking in previous quarter at 898.

EPS Net TTM Q/Q Growth Statistics
High Average Low
68.09 %
5.88 %
-28.8 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 17
Healthcare Sector # 54
Overall # 717

EPS Net TTM Y/Y Growth Statistics
High Average Low
141.32 %
30.31 %
-41.08 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 62
S&P 500 # 864




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ZTS's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ZTS's Competitors
EPS Net Growth for Zoetis's Suppliers
EPS Net Growth for ZTS's Customers

You may also want to know
ZTS's Annual Growth Rates ZTS's Profitability Ratios ZTS's Asset Turnover Ratio ZTS's Dividend Growth
ZTS's Roe ZTS's Valuation Ratios ZTS's Financial Strength Ratios ZTS's Dividend Payout Ratio
ZTS's Roa ZTS's Inventory Turnover Ratio ZTS's Growth Rates ZTS's Dividend Comparisons



Companies with similar EPS Net jump for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2019
Abiomed Inc -1.03 %$ -1.026 
Anika Therapeutics, Inc. -1.47 %$ -1.471 
Zoetis Inc. -2.53 %$ -2.532 
Hca Healthcare, Inc. -2.60 %$ -2.597 
Electromed, Inc. -2.91 %$ -2.907 
Pra Health Sciences, Inc. -3.13 %$ -3.125 
Select Medical Holdings Corp -5.71 %$ -5.714 
Chemed Corporation -5.81 %$ -5.810 
Radnet, Inc. -9.09 %$ -9.091 
Exelixis, Inc. -10.71 %$ -10.714 
Edwards Lifesciences Corporation -13.64 %$ -13.636 
Zynex Inc -14.29 %$ -14.286 
Hologic, Inc -14.63 %$ -14.634 
Laboratory Corp Of America Holdings -14.98 %$ -14.978 
Henry Schein, Inc. -16.30 %$ -16.304 
Acadia Healthcare Company, Inc. -17.91 %$ -17.910 
Pacific Health Care Organization Inc -20.00 %$ -20.000 
Charles River Laboratories International Inc -20.00 %$ -20.000 
Biotelemetry, Inc. -20.69 %$ -20.690 
Foamix Pharmaceuticals Ltd. -23.91 %$ -23.913 
Meridian Bioscience Inc -25.00 %$ -25.000 
Becton, Dickinson And Company -25.62 %$ -25.616 
Hanger, Inc. -25.71 %$ -25.714 
Icu Medical Inc -26.39 %$ -26.389 
Zimmer Biomet Holdings, Inc. -27.78 %$ -27.778 
Hill-rom Holdings, Inc. -28.36 %$ -28.358 
Integrated Biopharma Inc -29.30 %$ -29.301 
Molecular Templates, Inc. -30.56 %$ -30.556 
Inogen Inc -30.77 %$ -30.769 
Healthcare Services Group Inc -31.43 %$ -31.429 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TLYS's Profile

Stock Price

TLYS's Financials

Business Description

Fundamentals

Charts & Quotes

TLYS's News

Suppliers

TLYS's Competitors

Customers & Markets

Economic Indicators

TLYS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071